Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03690375 · ClinicalTrials.gov registry record · NA
Broad Band Light for the Treatment and Prevention of Senile Purpura
A NA study, sponsored by Siperstein Dermatology.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03690375: Completed NA study, sponsored by Siperstein Dermatology.
NCT03690375 is a NA study that has completed, run by Siperstein Dermatology. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03690375, a NA study, has completed, sponsored by Siperstein Dermatology.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
There will be five subjects over the age of 65, each with at least one ecchymotic lesion on each arm measuring at least one cm, and five control subjects under the age of 35, both who will be randomized to undergo 4 Sciton Broad Band Light (BBL) treatments on either their left or right arm one week apart. Subjects will fill out questionnaires, have pictures of their lower arms taken, and will be graded and measured by evaluators regarding the number and size of their ecchymoses as well as side effects such as blistering, pain, erythema, and swelling. One day after their 4th treatment on each arm, subjects will have biopsies done to be analyzed for changes in histology and gene expression. The subjects will follow up 1 month after their last treatments for final pictures of their lower arms and evaluations.
Primary Outcome
The number of purpuric lesions 30 days after the last treatment will be subtracted from the number of purpuric lesions at baseline
Interventions
- DEVICE Broad Band Light (BBL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-08-27 |
| Est. Completion | 2019-11-11 |
| Phase | NA |
What the finished NCT03690375 record still lists
NCT03690375 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Broad Band Light (BBL) is the first listed.
NCT03690375 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03690375 about?
NCT03690375 is a clinical study titled "Broad Band Light for the Treatment and Prevention of Senile Purpura". There will be five subjects over the age of 65, each with at least one ecchymotic lesion on each arm measuring at least one cm, and five control subjects under the age of 35, both who will be randomized to undergo 4 Sciton Broad Band Light (BBL) treatments on either their left or right arm one week ...
What is the current status of trial NCT03690375?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-08-27. Estimated completion is 2019-11-11.
What interventions are being tested in trial NCT03690375?
The interventions under investigation include: Broad Band Light (BBL) (DEVICE).
Who is sponsoring clinical trial NCT03690375?
This trial is sponsored by Siperstein Dermatology, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03690375's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI